Prioritizing biologically motivated approaches in Mendelian randomization studies

FHS
March 2, 2024
4:38 am

Mendelian randomization, a powerful tool in medical research, helps us understand whether certain factors truly cause disease.

Pharma goes to Washington, Alnylam’s future, & Gilead’s dealmaking

Has PhRMA lost its fangs? Are 11th-hour changes ominous for clinical trials? And what’s next in pain medicine? We cover all that and more this

February 15, 2024

Medicaid rebukes states for mistakenly disenrolling children

Medicaid warned states Wednesday that they could be mistakenly removing children from government insurance programs in a post-pandemic review of millions of enrollees. States may

August 30, 2023

Medacta Group SA reports robust revenue growth of 19.5% at constant currency and adjusted EBITDA1 margin 26.3%, or 27.9% at constant currency in FY 2023 – Biotech Investments

Medacta Group SA / Key word(s): Annual Results/Annual Results 13-March-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The

March 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.